_ Princi P al ^nvesiigaiof /Program Director (Last, hrst, middle). 
BIOGRAPHICAL SKETCH 
Give the following information for the key personnel and consultants and collaborators. Begin with the principal 
investigator/program director. Photocopy this page for each person 
NAME POSITION TITLE 
Friedrich SCHUENING Assistant Member, FHCRC 
EDUCATION (Begin with baccalaureate or other initial professional education, such as nursing, and include postdoctoral training ) 
INSTITUTION AND LOCATION 
DEGREE 
YEAR 
CONFERRED 
FIELD OF STUDY 
University of Mainz, Germany 
University of Hamburg, Germany 
| 
l 
1 
BA 
MD 
1968 
1976 
Theology 
Medicine 
RESEARCH AND PROFESSIONAL EXPERIENCE: Concluding with present position, list, in chronological order, previous employment, experience, and 
honors. Key personnel indude the principal investigator and any other individuals who partidpate in the scientific development or execution of the projecl 
Key personnel typically will indude all individuals with dodoral or other professional degrees, but in some projects will indude individuals at the masters or 
baccalaureate level provided they contribute in a substantive way to the sdentific development or execution of the project. Include present membership on 
any Federal Government public advisory committee. List, in chronological order, the titles, all authors, and complete references to all publications during the 
past three years and to representative earlier publications pertinent to this application. DO NOT EXCEED TWO PAGES. 
1976- 1976 
1977- 1979 
! 1979-1983 
1984-1986 
1986-1990 
1990-date 
Intern, University Hospital of Hamburg, West Germany 
Resident in Internal Medicine, Allgemeines Krankenhaus, Hagen, West Germany 
Staff Specialist in Medical Oncology, West German Cancer Center, Essen, West Germany 
Visiting Scientist, Fred Hutchinson Cancer Research Center, Seattle WA 
Associate in Clinical Research, FHCRC, Seattle WA 
Assistant Member, Clinical Research Division, FHCRC, Seattle, WA 
! Publications (selected from over 80) 
! l 
Ohl S, Schuning F, Ruther U,et al. Raynaud like phenomenon in progressive GVHD. In: Touraine J-L, 
Gluckman E, Griscelli C (eds): Bone Marrow Transplantation in Europe, Vol. II. Amsterdam, Oxford, 
Princeton: Excerpta Medica, p. 139-143, 1981. 
Schaefer UW, Schuning F,et al. Zellersatz und knochenmarktransplantation in der behandlung akuter 
leukamien. In: Scheurlen PG, Pees HW (eds): Aktuelle Therapie Bosartiger Blutkrankheiten. Berlin, 
Heidelberg, New York: Springer-Verlag, p. 128-138, 1982. 
Schuning F, et al. Knochenmarktransplantation bei panmyelopathie und bei akuter leukamie. Verh Dtsch Ges 
Inn Med 88: 946-948, 1982. 
Schaefer UW, Schuning F. Knochenmarktransplantation am West Deutschen Tumorzentrum Essen. In: 
Schmidt CG (ed): Aktuelle Probleme der Hamatologie und internistischen Onkologie. Berlin, Heidelberg, 
New York: Springer-Verlag, p. 113-124, 1983. 
Schaefer UW, Mahmoud HK, Schuning F, Schmidt CG, Becher R, Nowrousian MR, Ohl S, Wetter 0, Bamberg 
M, Alberti W, Schmitt G, Quast U, Scherer E, Haralambie E, Linzenmeier G, Gross-Wilde H, Kuwert E, 
Henneberg K-B, Luboldt W, Richter H-J, Leder LD, Hantschke D. Knochenmarktransplantationen bei 
panmyelopathie und leukamien. Deutsche Medizinische Wochenschrift 109: 1909-1913, 1984. 
Mahmoud HK, Schaefer UW, Schuening F, Schmidt CG, Grosse-Wilde H, Becher R, Lumboldt W. Late relapse 
of acute nonlymphoblastic leukaemia 6 years following allogeneic bone marrow transplantation. Br J 
Haematol 59: 725-741, 1985. 
Grosse-Wilde H, Krumbacher K, Schuning F, Doxiadis I, Mahmoud HK, Emde C, Schmidt-Weinmar A, Schaefer 
UW. Immune transfer studies in canine allogeneic marrow graft donor-recipient pairs. Transplantation 
42: 64-67, 1986. 
Kwok WW, Schuning F, Stead RB, Miller AD. Retroviral transfer of genes into canine hemopoietic progenitor 
cells in culture: A model for human gene therapy. Proc Natl Acad Sci USA 83: 4552-4555, 1986. 
Schuening F, Storb R, Goehle S, Meyer J, Graham T, Deeg HJ, Pesando J. Canine pluripotent hemopoietic 
stem cells and CFU-GM express la-like antigens as recognized by two different class-ll specific 
monoclonal antibodies. Blood 69: 165-172, 1987. 
(Form Page 6) Page 
PHS 398 (Rev. 9/91) 
Number pages consecutively at the bottom throughout the application Do not use suflixes such as 3a. 3b. 
Recombinant DNA Research, Volume 18 
[687] 
